Cargando…

Practical challenges in patients with stage III NSCLC receiving checkpoint inhibitors after chemoradiation

Detalles Bibliográficos
Autores principales: Shukla, Nikhil A, Hanna, Nasser H
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Future Medicine Ltd 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7110574/
https://www.ncbi.nlm.nih.gov/pubmed/32256709
http://dx.doi.org/10.2217/lmt-2020-0001
_version_ 1783513075151798272
author Shukla, Nikhil A
Hanna, Nasser H
author_facet Shukla, Nikhil A
Hanna, Nasser H
author_sort Shukla, Nikhil A
collection PubMed
description
format Online
Article
Text
id pubmed-7110574
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Future Medicine Ltd
record_format MEDLINE/PubMed
spelling pubmed-71105742020-04-02 Practical challenges in patients with stage III NSCLC receiving checkpoint inhibitors after chemoradiation Shukla, Nikhil A Hanna, Nasser H Lung Cancer Manag Editorial Future Medicine Ltd 2020-02-06 /pmc/articles/PMC7110574/ /pubmed/32256709 http://dx.doi.org/10.2217/lmt-2020-0001 Text en © 2020 Nikhil Shukla This work is licensed under the Attribution-NonCommercial-NoDerivatives 4.0 Unported License (http://creativecommons.org/licenses/by-nc-nd/4.0/)
spellingShingle Editorial
Shukla, Nikhil A
Hanna, Nasser H
Practical challenges in patients with stage III NSCLC receiving checkpoint inhibitors after chemoradiation
title Practical challenges in patients with stage III NSCLC receiving checkpoint inhibitors after chemoradiation
title_full Practical challenges in patients with stage III NSCLC receiving checkpoint inhibitors after chemoradiation
title_fullStr Practical challenges in patients with stage III NSCLC receiving checkpoint inhibitors after chemoradiation
title_full_unstemmed Practical challenges in patients with stage III NSCLC receiving checkpoint inhibitors after chemoradiation
title_short Practical challenges in patients with stage III NSCLC receiving checkpoint inhibitors after chemoradiation
title_sort practical challenges in patients with stage iii nsclc receiving checkpoint inhibitors after chemoradiation
topic Editorial
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7110574/
https://www.ncbi.nlm.nih.gov/pubmed/32256709
http://dx.doi.org/10.2217/lmt-2020-0001
work_keys_str_mv AT shuklanikhila practicalchallengesinpatientswithstageiiinsclcreceivingcheckpointinhibitorsafterchemoradiation
AT hannanasserh practicalchallengesinpatientswithstageiiinsclcreceivingcheckpointinhibitorsafterchemoradiation